title: [Prevention and treatment of the complications of polycystic ovarian syndrome--the significance of evidence-based, interdisciplinary management].
abstract: Polycystic ovary syndrome is the most common hormonal and metabolic disorder likely to affect women. The syndrome is often associated with obesity, hyperinsulinemia and adversely affects endocrine, metabolic, and cardiovascular health. The complex feature of the syndrome requires an interdisciplinary approach to treatment, where cooperation of paediatrician, internist, gynaecologist, endocrinologist, dermatologist, psychologist and oncologist is essential. The prevention and the treatment should be based on the best available evidence. This should include physical examination, laboratory tests for hormones, serum insulin, glucose, lipids, in addition patient's preferences should be considered, too. To maximise health gain of polycystic ovarian syndrome, adequate, effective, efficient and safe treatment is necessary. This article summarises the highest available evidence provided by meta-analyses and systematic reviews of the prevention of metabolic and cardiovascular complications of the syndrome, and discusses the relevant evidence published in the literature.
authors.affiliation: Megelőző Orvostani Intézet, Debreceni Egyetem, Népegészségügyi Kar Debrecen, Kassai u. 26., 4028.
authors.forename: Sándor
authors.initials: S
authors.lastname: Gődény
authors.affiliation: Megelőző Orvostani Intézet, Debreceni Egyetem, Népegészségügyi Kar Debrecen, Kassai u. 26., 4028.
authors.forename: Orsolya Karola
authors.initials: OK
authors.lastname: Csenteri
mesh_terms: D015415:Biomarkers / Q000097:blood*; D003376:Counseling; D003880:Dermatology; D003924:Diabetes Mellitus, Type 2 / Q000209:etiology / Q000517:prevention & control; D019468:Disease Management; D004704:Endocrinology; D019317:Evidence-Based Medicine; D005260:Female; D006628:Hirsutism / Q000209:etiology / Q000628:therapy; D006801:Humans; D006946:Hyperinsulinism / Q000209:etiology; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007247:Infertility, Female / Q000209:etiology / Q000628:therapy; D033183:Interdisciplinary Communication; D007388:Internal Medicine; D008495:Medical Oncology; D008687:Metformin / Q000627:therapeutic use*; D009765:Obesity / Q000209:etiology / Q000517:prevention & control; D010348:Patient Care Team; D010372:Pediatrics; D011085:Polycystic Ovary Syndrome / Q000097:blood / Q000150:complications* / Q000517:prevention & control / Q000628:therapy*; D011584:Psychology; D012307:Risk Factors; D040242:Risk Reduction Behavior
chemical_list: D015415:Biomarkers; D007004:Hypoglycemic Agents; D008687:Metformin
keywords: EBM; PCOS; interdisciplinary; interdiszciplináris; prevenció; prevention; terápia; treatment